Viva BioInnovator (VBI) is the specialized investment and incubation division of Viva Biotech Holdings, dedicated to investing globally in early-stage biotech innovation with novel solutions to unmet medical needs. It provides both cash and in-kind equity-for-services funding to support drug R&D, company formation, and early-stage development.
62% of their portfolio is in Biotech & Life Sciences. They made 2 investments in the last 12 months. Their most common stage is series-a (43% of deals). Average disclosed round size is $24.4M (across 19 rounds with reported amounts).
Portfolio
16
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
21 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Kainova Therapeutics | Series B | — | Feb 2026 |
| PProviva Therapeutics | Series A | $30M | Dec 2025 |
| PProviva Therapeutics | Series A | $30M | Jan 2025 |
 Proviva | Series A | $30M | Jan 2025 |
 Deka Biosciences | Seed | $20M | Jan 2023 |
 Domain Therapeutics | Series A | $42M | May 2022 |
 Haya Therapeutics | Seed | $5M | Feb 2022 |
| Domain Therapeutics | Series A | $42M | Jan 2022 |
 ABM Therapeutics | Series B | $30M | Jan 2022 |
| Kainova Therapeutics | Series A | $42M | Jan 2022 |
 Fuse Biotherapeutics, Inc | Seed | $9.5M | Nov 2021 |
 DTx Pharma | Series B | $100M | Mar 2021 |
 Iterion Therapeutics | Series B | $17M | Feb 2021 |
| Haya Therapeutics | Seed | $5M | Jan 2021 |
| PPhenomic AI | Seed | $6M | Jan 2020 |
 AmacaThera | Series A | $10.3M | Jan 2019 |
 IpiNovyx Bio | Seed | $10M | — |
| GGT Apeiron Therapeutics | Series A | $17.5M | — |
| PPhenomic AI | Pre-Seed | — | — |
 Amberstone Biosciences | Series A | $12M | — |
| RRiparian Pharmaceuticals | Unknown | $6M | — |
Top Co-Investors
Panacea Venture5 shared
3B Future Health Fund4 shared
Turenne Capital4 shared
Schroders Capital4 shared
adMare BioInnovations4 shared
Omnes Capital3 shared
Hankang Capital3 shared
OrbiMed3 shared
Investissement Québec2 shared
Eli Lilly and Company2 shared
Alexandria Venture Investments2 shared
HongShan2 shared
Luminous Ventures2 shared
AV8 Ventures2 shared
Humboldt Fund2 shared
Apollo Health Ventures2 shared
Sofinnova Partners2 shared
Broadview Ventures2 shared
EQT Life Sciences1 shared
Seventure Partners1 shared
Last updated: 7 October 2026